Literature DB >> 23486498

Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.

Yuhua Ruan1, Shu Liang, Junling Zhu, Xudong Li, Stephen W Pan, Qianping Liu, Benli Song, Qixing Wang, Hui Xing, Yiming Shao.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the impact of a multifaceted harm reduction program by comparing seroincidence rates of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and syphilis before and after implementation of harm reduction strategies among intravenous drug users (IDUs) in a drug-trafficking city in Southwest China.
DESIGN: This is a prospective cohort study with 24 months of follow-up.
METHODS: Two prospective cohorts (cohort 2002-2004 and cohort 2006-2008) were followed up every 6 months for seroconversions of HIV, HCV, and syphilis antibodies and HBV surface antigen.
RESULTS: After implementation of harm reduction strategies in Xichang city, Sichuan province, the HIV incidence rate among IDUs significantly dropped from 2.5 to 0.6 cases per 100 person-years. Subanalyses also indicated that the incidence rate of HBV significantly declined from 14.2 to 8.8 cases per 100 person-years. No significant changes in the seroincidence rates of HCV or syphilis were detected after implementation of IDU harm reduction strategies.
CONCLUSIONS: Harm reduction strategies may help reduce the high incidence of certain blood-borne infectious diseases and sexual transmitted diseases among high-risk IDUs in southwest China. Additional research is needed on the implementation and evaluation of harm reduction strategies in China.

Entities:  

Mesh:

Year:  2013        PMID: 23486498     DOI: 10.1097/OLQ.0b013e31827fd4d4

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  21 in total

1.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Authors:  Vana Sypsa; Mina Psichogiou; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Dimitra Paraskeva; Katerina Micha; Meni Malliori; Anastasia Pharris; Lucas Wiessing; Martin Donoghoe; Samuel Friedman; Don Des Jarlais; Georgios Daikos; Angelos Hatzakis
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

Review 2.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

3.  Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.

Authors:  Yi Yang; Carl Latkin; Rongsheng Luan; Cui Yang
Journal:  Int J Drug Policy       Date:  2015-06-09

4.  Seroepidemiology of hepatitis B virus infection and impact of vaccination.

Authors:  Peng Huang; Li-Guo Zhu; Ye-Fei Zhu; Ming Yue; Jing Su; Feng-Cai Zhu; Hai-Tao Yang; Yun Zhang; Hong-Bing Shen; Rong-Bin Yu; Xiang-Jun Zhai; Zhi-Hang Peng
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012.

Authors:  P Huang; L G Zhu; X J Zhai; Y F Zhu; M Yue; J Su; J Wang; H T Yang; Y Zhang; H B Shen; Z H Peng; R B Yu
Journal:  Epidemiol Infect       Date:  2015-01-20       Impact factor: 4.434

6.  A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.

Authors:  Yi Yang; Carl A Latkin; Rongsheng Luan; Cui Yang
Journal:  BMC Public Health       Date:  2015-09-14       Impact factor: 3.295

7.  Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.

Authors:  Xia Zou; Li Ling; Lei Zhang
Journal:  BMJ Open       Date:  2015-08-21       Impact factor: 2.692

8.  HIV, syphilis, and behavioral risk factors among female sex workers before and after implementation of harm reduction programs in a high drug-using area of China.

Authors:  Li Zhang; Shu Liang; Weixia Lu; Stephen W Pan; Benli Song; Qianping Liu; Yunan Xu; Hui Dong; Hui Xing; Yiming Shao; Yuhua Ruan
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Trends of HIV subtypes and phylogenetic dynamics among young men who have sex with men in China, 2009-2014.

Authors:  Zheng Li; Lingjie Liao; Yi Feng; Jing Zhang; Jing Yan; Cui He; Wei Xu; Yuhua Ruan; Hui Xing; Yiming Shao
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

10.  Virological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012.

Authors:  Jing Wang; Cui He; Jenny H Hsi; Xiaoqin Xu; Yong Liu; Jianmei He; Hua Ling; Ping Ding; Yi Tong; Xiaobai Zou; Quanhua Zhou; Lingjie Liao; Xia Wang; Yuhua Ruan; Yiming Shao; Hui Xing
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.